NEENAH, WI, July 29, 2026 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) today announced financial
results for our fiscal third quarter ended July 4, 2026, and guidance for our fiscal fourth quarter ending October
3, 2026.
- Reports record fiscal third quarter 2026 revenue
of $1.305 billion, GAAP operating margin of 4.7% and GAAP diluted EPS of $1.58.
- Reports fiscal third quarter 2026 non-GAAP
operating margin of 6.3% and non-GAAP diluted EPS of $2.32, excluding $0.74 of stock-based compensation expense.
- Initiates fiscal fourth quarter 2026 revenue guidance of $1.330
billion to $1.380 billion with GAAP diluted EPS of $2.18 to $2.34, including $0.29 of stock-based compensation
expense. Fiscal fourth quarter non-GAAP EPS guidance of $2.47 to $2.63 excludes stock-based compensation
expense.
| |
|
| |
Three Months
Ended |
| |
July 4, 2026 |
|
July 4, 2026 |
|
Oct 3, 2026 |
| |
Q3F26 Results |
|
Q3F26 Guidance |
|
Q4F26 Guidance |
| Summary GAAP Items |
|
|
|
|
|
| Revenue (in
billions) |
$ |
1.305 |
|
|
$1.200 to $1.250 |
|
$1.330 to $1.380 |
| Operating margin |
|
4.7 |
% |
|
4.1% to 4.5% |
|
5.5% to 5.9% |
| Diluted EPS |
$ |
1.58 |
|
|
$1.25 to $1.41 |
|
$2.18 to $2.34 |
| |
|
|
|
|
|
| Summary Non-GAAP Items (1) |
|
|
|
|
|
| Adjusted operating margin (2) |
|
6.3 |
% |
|
5.9% to 6.3% |
|
6.1% to 6.5% |
| Adjusted EPS (3) |
$ |
2.32 |
|
|
$2.02 to $2.18 |
|
$2.47 to $2.63 |
| Return on invested capital (ROIC) |
|
14.9 |
% |
|
|
|
|
| Economic return |
|
5.9 |
% |
|
|
|
|
|
(1) |
Refer to Non-GAAP Supplemental Information tables for additional information regarding non-GAAP
financial measures. |
|
(2) |
Excludes stock-based compensation expense of approximately 160 bps for Q3F26 results, 180 bps for
Q3F26 guidance and 60 bps for Q4F26 guidance. |
|
(3) |
Excludes stock-based compensation expense, net of tax, of $0.74 for Q3F26 results, $0.77 for Q3F26
guidance and $0.29 for Q4F26 guidance. |
| |
|
Fiscal Third Quarter
2026 Information
- Won 31 manufacturing programs during the quarter representing $255
million in annualized revenue when fully ramped into production.
- Purchased $20.6 million of our shares at an average price of $258.75
per share under our 2026 Share Repurchase Program, leaving $21.4 million available under our existing $100.0
million authorization.
Todd Kelsey, President and Chief Executive Officer, commented, “Plexus generated record quarterly
revenue in the fiscal third quarter by capturing strengthening end market demand and successfully launching
numerous new programs. Fiscal third quarter revenue of $1.305 billion exceeded guidance, increasing 12%
sequentially and 28% year over year. In addition, non-GAAP operating margin of 6.3% met the high end of
guidance, non-GAAP EPS of $2.32 exceeded guidance and we again delivered healthy working capital
efficiency.”
Mr. Kelsey added, “Our go-to-market team continued to drive strong performance with quarterly
manufacturing wins of $255 million in annualized revenue. This result included significant wins for our
Aerospace/Defense market sector as well as a new partnership in our Industrial market sector manufacturing a
battery energy storage system for data centers. Furthermore, we expanded our funnel of qualified manufacturing
opportunities to $4.5 billion, a record level, supporting the potential to sustain robust long-term revenue
growth.”
David Abuhl, Senior Vice President and Chief Financial Officer, commented, “Driven by continued
progress on our working capital initiatives, our cash cycle of 62 days exceeded expectations. This outstanding
result is the best quarterly cash cycle performance in over five years. In support of accelerating revenue
growth, we had a slight usage of free cash flow in the quarter, which was better than our expectations. While we
expect to maintain cash cycle days in the low-to-mid 60s for the fiscal fourth quarter, further working capital
investments are required to support our substantial revenue growth projections. As such, we now expect a usage
of free cash flow for fiscal 2026 with a return to meaningful free cash flow generation in early fiscal 2027.”
Mr. Abuhl continued, “Our favorable cash cycle days, prudent capital expenditures and strong
operating performance produced a return on invested capital of 14.9% in the quarter, up 110 basis points versus
the prior quarter and 590 basis points above our cost of capital. This result represented the highest return in
nearly five years.”
Mr. Kelsey continued, “For our fiscal fourth quarter, we forecast continued revenue growth led by
strength in our Healthcare/Life Sciences and Industrial market sectors, including our semiconductor capital
equipment subsector. We are guiding revenue of $1.330 to $1.380 billion, up 4% sequentially and 28% year over
year at the midpoint, non-GAAP operating margin of 6.1% to 6.5% and non-GAAP EPS of $2.47 to $2.63. For fiscal
2026, we now anticipate generating in excess of 20% revenue growth due to Plexus’ success in launching numerous
new programs and our market share gains combined with improved end market demand. Additionally, we expect to
deliver this considerable revenue growth with greater than 6% non-GAAP operating margin and healthy working
capital efficiency.”
Mr. Kelsey concluded, “Our differentiated value proposition, focused on providing unmatched
quality and delivery, is resulting in robust performance for fiscal 2026 and positions Plexus for sustained,
long-term momentum. We currently see the potential to generate fiscal 2027 revenue growth in excess of our 9% to
12% goal led by our Aerospace/Defense and Industrial market sectors, including our semiconductor capital
equipment subsector. In addition, we anticipate delivering operating margin expansion, while continuing to make
important investments in talent and technology in support of future growth.”
| |
|
| Quarterly Comparison |
Three
Months Ended |
| (in thousands, except EPS) |
July 4, 2026 |
|
Apr 4, 2026 |
|
Jun 28, 2025 |
| Revenue |
$ |
1,304,778 |
|
|
$ |
1,163,757 |
|
|
$ |
1,018,308 |
|
| Gross profit |
|
131,379 |
|
|
|
119,176 |
|
|
|
103,288 |
|
| Operating income |
|
61,260 |
|
|
|
61,837 |
|
|
|
53,608 |
|
| Net income |
|
42,993 |
|
|
|
49,809 |
|
|
|
45,116 |
|
| Diluted EPS |
$ |
1.58 |
|
|
$ |
1.82 |
|
|
$ |
1.64 |
|
| |
|
|
|
|
|
| Gross margin |
|
10.1 |
% |
|
|
10.2 |
% |
|
|
10.1 |
% |
| Operating margin |
|
4.7 |
% |
|
|
5.3 |
% |
|
|
5.3 |
% |
| |
|
|
|
|
|
| ROIC (1) |
|
14.9 |
% |
|
|
13.8 |
% |
|
|
14.1 |
% |
| Economic return (1) |
|
5.9 |
% |
|
|
4.8 |
% |
|
|
5.2 |
% |
| |
|
|
|
|
|
| (1) Refer
to Non-GAAP Supplemental Information tables for non-GAAP financial measures discussed and/or
disclosed in this release, such as adjusted operating margin, adjusted net income, adjusted diluted
EPS, ROIC and economic return. |
| |
Business Segment and Market Sector Revenue
Plexus measures operational performance and allocates resources on a geographic segment basis. Plexus
also reports revenue based on the market sector breakout set forth in the table below, which reflects Plexus’ market
sector focused strategy. Top 10 customers comprised 55% of revenue during the third quarter of fiscal 2026. This is
up 1 percentage point from the second quarter of fiscal 2026 and up 7 percentage points from the third quarter of
fiscal 2025.
| Business Segments ($ in millions) |
Three
Months Ended |
| |
|
July 4, 2026 |
|
Apr 4, 2026 |
|
Jun 28, 2025 |
| Americas |
$ |
428 |
|
|
$ |
397 |
|
|
$ |
312 |
|
| Asia-Pacific |
|
774 |
|
|
|
652 |
|
|
|
594 |
|
| Europe, Middle East and Africa |
|
109 |
|
|
|
116 |
|
|
|
117 |
|
| Elimination of inter-segment sales |
|
(6 |
) |
|
|
(1 |
) |
|
|
(5 |
) |
|
Total Revenue |
$ |
1,305 |
|
|
$ |
1,164 |
|
|
$ |
1,018 |
|
| |
|
|
|
|
|
|
| Market Sectors ($ in millions) |
Three
Months Ended |
| |
July 4, 2026 |
|
Apr 4, 2026 |
|
Jun 28, 2025 |
| Aerospace/Defense |
$ |
233 |
|
18 |
% |
|
$ |
212 |
|
18 |
% |
|
$ |
183 |
|
18 |
% |
| Healthcare/Life Sciences |
|
483
|
|
37
|
% |
|
|
473
|
|
41
|
% |
|
|
420
|
|
41
|
% |
| Industrial |
|
589 |
|
45
|
% |
|
|
479 |
|
41
|
% |
|
|
415 |
|
41
|
% |
|
Total Revenue |
$ |
1,305 |
|
|
|
$ |
1,164 |
|
|
|
$ |
1,018 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Supplemental Information
Plexus provides non-GAAP supplemental information, such as ROIC, economic return and free cash flow,
because such measures are used for internal management goals and decision-making, and because they provide
management and investors with additional insight into financial performance. In addition, management uses these and
other non-GAAP measures, such as adjusted operating income, adjusted operating margin, adjusted net income and
adjusted diluted EPS, to provide a better understanding of core performance for purposes of period-to-period
comparisons. Plexus believes that these measures are also useful to investors because they provide further insight
by eliminating the effect of non-recurring items that are not reflective of continuing operations. For additional
information on non-GAAP measures, please refer to the attached Non-GAAP Supplemental Information tables.
ROIC and Economic Return
ROIC for the third quarter of fiscal 2026 was 14.9%. Plexus defines ROIC as tax-effected annualized
adjusted operating income divided by average invested capital over a four-quarter period for the third fiscal
quarter. Invested capital is defined as equity plus debt and operating lease obligations, less cash and cash
equivalents. Plexus' weighted average cost of capital for fiscal 2026 is 9.0%. ROIC for the third quarter of fiscal
2026 less Plexus’ weighted average cost of capital resulted in an economic return of 5.9%.
Free Cash Flow
Plexus defines free cash flow as cash flows provided by operations less capital expenditures. For the
three months ended July 4, 2026, cash flows provided by operations was $25.9 million and capital expenditures
were $26.6 million, which resulted in a usage of free cash flow of $0.7 million.
| Cash Cycle Days |
Three Months
Ended |
| |
July 4, 2026 |
|
Apr 4, 2026 |
|
Jun 28, 2025 |
| Days in Accounts
Receivable |
56 |
|
|
55 |
|
|
59 |
|
| Days in Contract Assets |
13
|
|
|
12
|
|
|
13
|
|
| Days in Inventory |
116
|
|
|
120
|
|
|
128
|
|
| Days in Accounts Payable |
(76
|
) |
|
(74
|
) |
|
(72
|
) |
| Days in Advanced Payments |
(47 |
) |
|
(49 |
) |
|
(59 |
) |
|
Annualized Cash Cycle (1) |
62 |
|
|
64 |
|
|
69 |
|
|
(1) |
Plexus calculates cash cycle as the sum of days in accounts receivable, days in contract assets and
days in inventory, less days in accounts payable and days in advanced payments. |
| |
|
Conference Call and Webcast Information
|
What: |
Plexus Fiscal 2026 Q3 Earnings
Conference Call and Webcast |
| When: |
Thursday, July 30, 2026 at 8:30 a.m. Eastern Time |
| Where: |
Participants are
encouraged to join the live webcast at the investor relations section of the Plexus website, plexus.com. Participants can also join utilizing the links
below:
Webcast link: https://events.q4inc.com/attendee/435522461
|
| Replay: |
The webcast will be
archived on the Plexus website and will be available as on-demand for 12 months |
| |
|
Investor and Media Contact
Shawn Harrison
+1.920.969.6325
shawn.harrison@plexus.com
About Plexus
At Plexus, we help create the products that build a better world.
Driven by a passion for excellence, we partner with our customers to design, manufacture and service highly complex
products in demanding regulatory environments. From life-saving medical devices and mission-critical aerospace and
defense products to industrial automation systems and semiconductor capital equipment, our innovative solutions
across the lifecycle of a product converge where advanced technology and human impact intersect. We provide these
solutions to market-leading as well as disruptive global companies in the Aerospace/Defense, Healthcare/Life
Sciences, and Industrial sectors, supported by a global team of over 20,000 members across our 27 facilities. For
more information about Plexus, visit our website at www.plexus.com.
Safe Harbor and Fair Disclosure Statement
The statements contained in this
press release that are guidance or which are not historical facts (such as statements in the future tense and
statements including believe, expect, intend, plan, anticipate, goal, target and similar terms and concepts),
including all discussions of periods which are not yet completed, are forward-looking statements that involve
risks and uncertainties. These risks and uncertainties include the effects of tariffs, trade disputes, trade
agreements and other trade protection measures; the effects of shortages, delays and price fluctuations in
obtaining components as a result of economic cycles, capacity constraints, natural disasters or otherwise; the
risk of customer delays, changes, cancellations or forecast inaccuracies in both ongoing and new programs; the
particular risks relative to new or recent customers, programs or services, which risks include customer and
other delays, start-up costs, potential inability to execute, the establishment of appropriate engagement terms,
and the lack of a track record of order volume and timing; the risk that new program wins and/or customer demand
may not result in the expected revenue or profitability; the lack of visibility of future orders, particularly
in view of changing economic conditions; the economic performance of the industries, sectors and customers we
serve; the effects of the volume of revenue from certain sectors or programs on our margins in particular
periods; our ability to secure new customers, maintain our current customers and deliver product on a timely
basis; the risks of concentration of work for certain customers; the effects of start-up costs of new programs
and facilities or the costs associated with winding down programs or the closure or consolidation of facilities;
possible unexpected costs and operating disruption in transitioning programs, including transitions between
Company facilities; the risks associated with excess and obsolete inventory, including the risk that inventory
purchased on behalf of our customers may not be consumed or otherwise paid for by the customer, resulting in an
inventory write-off; the fact that customer orders may not lead to long-term relationships; our ability to
manage successfully and execute a complex business model characterized by high product mix and demanding
quality, regulatory, and other requirements; the outcome of litigation and regulatory investigations and
proceedings, including the results of any challenges with regard to such outcomes; the ability to realize
anticipated savings from restructuring or similar actions, as well as the adequacy of related charges as
compared to actual expenses; risks related to information technology systems and data security; increasing
regulatory and compliance requirements; any tax law changes and related foreign jurisdiction tax developments;
current or potential future barriers to the repatriation of funds that are currently held outside of the United
States as a result of actions taken by other countries or otherwise; the potential effects of jurisdictional
results on our taxes, tax rates, and our ability to use deferred tax assets and net operating losses; the
weakness of the economy regionally or globally; the effect of changes in the pricing and margins of our
services; raw materials and component cost fluctuations; the potential effect of fluctuations in the value of
the currencies in which we transact business; the effects of changes in economic conditions, political
conditions and regulatory matters in the United States and in the other countries in which we do business; the
potential effect of other events outside our control, such as the conflict between Russia and Ukraine, conflict
in the Middle East (including in Iran), escalating tensions between China and Taiwan or China and the United
States, tensions in or amongst countries in which we operate or transact business; changes in energy prices,
terrorism, global health epidemics and weather events; the impact of increased competition; an inability to
successfully manage human capital, including succession planning for and transition of senior
executives; changes in financial accounting standards; and other risks detailed herein and in our other
Securities and Exchange Commission filings, particularly in Risk Factors contained in our fiscal 2025 Form
10-K.
| |
|
PLEXUS CORP. AND SUBSIDIARIES |
|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
| (in
thousands, except per share data) |
| (unaudited)
|
| |
|
|
|
|
|
| |
Three Months
Ended |
|
Nine Months Ended |
| |
Jul 4, |
|
Jun 28, |
|
Jul 4, |
|
Jun 28, |
| |
2026 |
|
2025 |
|
2026 |
|
2025 |
| Net sales |
$ |
1,304,778 |
|
|
$ |
1,018,308 |
|
|
$ |
3,538,387 |
|
|
$ |
2,974,600 |
|
| Cost of sales |
|
1,173,399 |
|
|
|
915,020 |
|
|
|
3,181,694 |
|
|
|
2,672,869 |
|
|
Gross profit |
|
131,379 |
|
|
|
103,288 |
|
|
|
356,693 |
|
|
|
301,731 |
|
| Operating expenses: |
|
|
|
|
|
|
|
|
Selling and administrative expenses |
|
70,119 |
|
|
|
49,680 |
|
|
|
179,132 |
|
|
|
147,789 |
|
|
Restructuring and other charges, net |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
4,683 |
|
|
Operating income |
|
61,260 |
|
|
|
53,608 |
|
|
|
177,561 |
|
|
|
149,259 |
|
| Other income (expense): |
|
|
|
|
|
|
|
|
Interest expense |
|
(4,089 |
) |
|
|
(2,501 |
) |
|
|
(10,399 |
) |
|
|
(9,192 |
) |
|
Interest income |
|
1,463 |
|
|
|
934 |
|
|
|
3,259 |
|
|
|
3,039 |
|
|
Miscellaneous, net |
|
(2,185 |
) |
|
|
(2,205 |
) |
|
|
(5,063 |
) |
|
|
(4,753 |
) |
|
Income before income taxes |
|
56,449 |
|
|
|
49,836 |
|
|
|
165,358 |
|
|
|
138,353 |
|
| Income tax expense |
|
13,456 |
|
|
|
4,720 |
|
|
|
31,374 |
|
|
|
16,897 |
|
|
Net income |
$ |
42,993 |
|
|
$ |
45,116 |
|
|
$ |
133,984 |
|
|
$ |
121,456 |
|
| Earnings per share: |
|
|
|
|
|
|
|
|
Basic |
$ |
1.61 |
|
|
$ |
1.67 |
|
|
$ |
5.01 |
|
|
$ |
4.48 |
|
|
Diluted |
$ |
1.58 |
|
|
$ |
1.64 |
|
|
$ |
4.90 |
|
|
$ |
4.39 |
|
| Weighted average shares outstanding: |
|
|
|
|
|
|
|
|
Basic |
|
26,712 |
|
|
|
27,059 |
|
|
|
26,745 |
|
|
|
27,084 |
|
|
Diluted |
|
27,294 |
|
|
|
27,532 |
|
|
|
27,347 |
|
|
|
27,670 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PLEXUS CORP. AND SUBSIDIARIES |
|
CONDENSED CONSOLIDATED BALANCE SHEETS |
| (in
thousands) |
| (unaudited)
|
| |
| |
Jul 4, |
|
Sep 27, |
| |
2026 |
|
2025 |
| ASSETS
|
|
|
|
| Current assets: |
|
|
|
|
Cash and cash equivalents |
$ |
314,053 |
|
|
$ |
306,464 |
|
|
Restricted cash |
|
514 |
|
|
|
294 |
|
|
Accounts receivable |
|
795,159 |
|
|
|
656,573 |
|
|
Contract assets |
|
193,942 |
|
|
|
150,654 |
|
|
Inventories |
|
1,488,391 |
|
|
|
1,229,839 |
|
|
Prepaid expenses and other |
|
103,285 |
|
|
|
54,969 |
|
|
Total current assets |
|
2,895,344 |
|
|
|
2,398,793 |
|
| Property, plant and equipment, net |
|
546,159 |
|
|
|
546,052 |
|
| Operating lease right-of-use assets |
|
66,560 |
|
|
|
72,863 |
|
| Deferred income taxes |
|
95,173 |
|
|
|
91,349 |
|
| Other assets |
|
30,361 |
|
|
|
28,053 |
|
|
Total non-current assets |
|
738,253 |
|
|
|
738,317 |
|
|
Total assets |
$ |
3,633,597 |
|
|
$ |
3,137,110 |
|
| |
|
|
|
| LIABILITIES AND SHAREHOLDERS’ EQUITY |
|
|
|
| Current liabilities:
|
|
|
|
|
Current portion of long-term debt and finance lease obligations |
$ |
183,814 |
|
|
$ |
45,793 |
|
|
Accounts payable |
|
978,899 |
|
|
|
726,597 |
|
|
Advanced payments from customers |
|
602,933 |
|
|
|
575,850 |
|
|
Accrued salaries and wages |
|
111,557 |
|
|
|
109,076 |
|
|
Other accrued liabilities |
|
68,563 |
|
|
|
61,367 |
|
|
Total current liabilities |
|
1,945,766 |
|
|
|
1,518,683 |
|
| Long-term debt and finance lease obligations, net of current portion
|
|
91,644 |
|
|
|
91,987 |
|
| Long-term operating
lease liabilities |
|
23,888 |
|
|
|
29,422 |
|
| Deferred income taxes
|
|
7,322 |
|
|
|
6,000 |
|
| Other liabilities |
|
36,225 |
|
|
|
36,430 |
|
|
Total non-current liabilities |
|
159,079 |
|
|
|
163,839 |
|
|
Total liabilities |
|
2,104,845 |
|
|
|
1,682,522 |
|
| Shareholders’ equity:
|
|
|
|
|
Common stock |
|
549 |
|
|
|
547 |
|
|
Additional paid-in-capital |
|
710,372 |
|
|
|
695,653 |
|
|
Common stock held in treasury |
|
(1,319,506 |
) |
|
|
(1,255,451 |
) |
|
Retained earnings |
|
2,130,012 |
|
|
|
1,996,028 |
|
|
Accumulated other comprehensive income |
|
7,325 |
|
|
|
17,811 |
|
|
Total shareholders’ equity |
|
1,528,752 |
|
|
|
1,454,588 |
|
|
Total liabilities and shareholders’ equity |
$ |
3,633,597 |
|
|
$ |
3,137,110 |
|
| |
|
|
|
|
PLEXUS CORP. AND SUBSIDIARIES |
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
| (in
thousands) |
| (unaudited)
|
| |
|
|
|
| |
Nine Months
Ended |
| |
Jul 4, |
|
Jun 28, |
| |
2026 |
|
2025 |
| Cash flows from
operating activities |
|
|
|
|
Net income |
$ |
133,984 |
|
|
$ |
121,456 |
|
|
Adjustments to reconcile net income to net cash flows from operating activities: |
|
|
|
|
Depreciation and amortization |
|
57,357 |
|
|
|
58,509 |
|
|
Share-based compensation expense and related charges |
|
36,820 |
|
|
|
22,466 |
|
|
Other, net |
|
(211 |
) |
|
|
(8,381 |
) |
|
Changes in operating assets and liabilities, excluding impacts of currency: |
|
|
|
|
Accounts receivable |
|
(140,201 |
) |
|
|
(37,265 |
) |
|
Contract assets |
|
(43,250 |
) |
|
|
(24,090 |
) |
|
Inventories |
|
(259,911 |
) |
|
|
37,543 |
|
|
Other current and non-current assets |
|
(47,874 |
) |
|
|
(1,262 |
) |
|
Accrued income taxes payable |
|
(3,930 |
) |
|
|
(13,361 |
) |
|
Accounts payable |
|
271,371 |
|
|
|
88,902 |
|
|
Advanced payments from customers |
|
27,444 |
|
|
|
(118,276 |
) |
|
Other current and non-current liabilities |
|
7,389 |
|
|
|
(9,028 |
) |
|
Cash flows provided by operating activities |
|
38,988 |
|
|
|
117,213 |
|
| Cash flows from
investing activities |
|
|
|
|
Payments for property, plant and equipment |
|
(74,312 |
) |
|
|
(60,441 |
) |
|
Other, net |
|
(258 |
) |
|
|
(412 |
) |
|
Cash flows used in investing activities |
|
(74,570 |
) |
|
|
(60,853 |
) |
| Cash flows from
financing activities |
|
|
|
|
Borrowings under debt agreements |
|
605,500 |
|
|
|
293,500 |
|
|
Payments on debt and finance lease obligations |
|
(476,674 |
) |
|
|
(402,875 |
) |
|
Debt issuance costs |
|
(1,108 |
) |
|
|
— |
|
|
Repurchases of common stock |
|
(64,055 |
) |
|
|
(43,807 |
) |
|
Payments related to tax withholding for share-based compensation |
|
(21,473 |
) |
|
|
(15,100 |
) |
|
Cash flows provided by (used in) financing activities |
|
42,190 |
|
|
|
(168,282 |
) |
| Effect of exchange rate
changes on cash and cash equivalents |
|
1,201 |
|
|
|
2,077 |
|
| Net increase (decrease)
in cash and cash equivalents and restricted cash |
|
7,809 |
|
|
|
(109,845 |
) |
| Cash and cash
equivalents and restricted cash: |
|
|
|
|
Beginning of period |
|
306,758 |
|
|
|
347,462 |
|
|
End of period |
$ |
314,567 |
|
|
$ |
237,617 |
|
| |
|
|
|
|
PLEXUS CORP. AND SUBSIDIARIES |
|
NON-GAAP SUPPLEMENTAL INFORMATION Table 1 |
| (in
thousands, except per share data) |
| (unaudited)
|
| |
|
|
|
|
|
|
|
|
|
| |
Three Months Ended |
|
Nine Months
Ended |
| |
Jul 4, |
|
Apr 4, |
|
Jun 28, |
|
Jul 4, |
|
Jun 28, |
| |
2026 |
|
2026 |
|
2025 |
|
2026 |
|
2025 |
| Operating income,
as reported |
$ |
61,260 |
|
|
$ |
61,837 |
|
|
$ |
53,608 |
|
|
$ |
177,561 |
|
|
$ |
149,259 |
|
| Operating margin, as reported |
|
4.7 |
% |
|
|
5.3 |
% |
|
|
5.3 |
% |
|
|
5.0 |
% |
|
|
5.0 |
% |
| |
|
|
|
|
|
|
|
|
|
| Non-GAAP adjustments: |
|
|
|
|
|
|
|
|
|
|
Restructuring costs (1) |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
4,683 |
|
|
Stock-based compensation (2) |
|
21,137 |
|
|
|
7,922 |
|
|
|
7,691 |
|
|
|
36,824 |
|
|
|
21,813 |
|
| Non-GAAP operating income |
$ |
82,397 |
|
|
$ |
69,759 |
|
|
$ |
61,299 |
|
|
$ |
214,385 |
|
|
$ |
175,755 |
|
| Non-GAAP operating margin |
|
6.3 |
% |
|
|
6.0 |
% |
|
|
6.0 |
% |
|
|
6.1 |
% |
|
|
5.9 |
% |
| |
|
|
|
|
|
|
|
|
|
| Net income, as reported |
$ |
42,993 |
|
|
$ |
49,809 |
|
|
$ |
45,116 |
|
|
$ |
133,984 |
|
|
$ |
121,456 |
|
| |
|
|
|
|
|
|
|
|
|
| Non-GAAP adjustments: |
|
|
|
|
|
|
|
|
|
|
Restructuring costs, net of tax (1) |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
4,191 |
|
|
Stock-based compensation, net of tax (2) |
|
20,337 |
|
|
|
6,055 |
|
|
|
7,307 |
|
|
|
33,769 |
|
|
|
20,722 |
|
| Adjusted net income |
$ |
63,330 |
|
|
$ |
55,864 |
|
|
$ |
52,423 |
|
|
$ |
167,753 |
|
|
$ |
146,369 |
|
| |
|
|
|
|
|
|
|
|
|
| Diluted earnings per share, as reported |
$ |
1.58 |
|
|
$ |
1.82 |
|
|
$ |
1.64 |
|
|
$ |
4.90 |
|
|
$ |
4.39 |
|
| |
|
|
|
|
|
|
|
|
|
| Non-GAAP per share adjustments: |
|
|
|
|
|
|
|
|
|
|
Restructuring costs, net of tax (1) |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.15 |
|
|
Stock-based compensation, net of tax (2) |
|
0.74 |
|
|
|
0.23 |
|
|
|
0.26 |
|
|
|
1.23 |
|
|
|
0.75 |
|
| Adjusted diluted earnings per share |
$ |
2.32 |
|
|
$ |
2.05 |
|
|
$ |
1.90 |
|
|
$ |
6.13 |
|
|
$ |
5.29 |
|
|
(1) |
During the nine months ended June 28, 2025, restructuring costs of $4.7 million, or $4.2 million net
of taxes, were incurred primarily for employee severance costs associated with a reduction in the
Company’s workforce in the EMEA and AMER regions. |
| (2) |
During the three and
nine months ended July 4, 2026, $12.9 million, or $12.5 million net of taxes ($0.46 per diluted
share), of accelerated stock-based compensation expense was recorded in selling and administrative
expenses in the accompanying Condensed Consolidated Statements of Operations as a result of
previously announced executive retirement agreements. |
| |
|
PLEXUS CORP. AND SUBSIDIARIES
|
NON-GAAP SUPPLEMENTAL INFORMATION Table 2
|
(in
thousands)
|
(unaudited)
|
| |
|
|
|
|
|
|
| ROIC and Economic Return Calculations
|
Nine Months Ended |
|
Six Months Ended |
|
Nine Months Ended |
| |
Jul 4, |
|
Apr 4, |
|
Jun 28, |
| |
2026 |
|
2026
|
|
2025 |
| Operating income,
as reported |
|
$ |
177,561 |
|
|
|
$ |
116,301 |
|
|
|
$ |
149,259 |
|
|
Restructuring and other charges, net |
|
|
— |
|
|
|
|
— |
|
|
|
|
4,683 |
|
|
Accelerated stock-based compensation (1) |
+ |
|
12,940 |
|
|
+ |
|
— |
|
|
+ |
|
— |
|
| Adjusted operating income |
|
$ |
190,501 |
|
|
|
$ |
116,301 |
|
|
|
$ |
153,942 |
|
| |
÷ |
|
3 |
|
|
x |
|
2 |
|
|
÷ |
|
3 |
|
| |
|
$ |
63,500 |
|
|
|
|
|
|
|
|
$ |
51,314 |
|
| |
x |
|
4 |
|
|
|
|
|
|
|
x |
|
4 |
|
| Adjusted annualized operating income |
|
$ |
254,000 |
|
|
|
$ |
232,602 |
|
|
|
$ |
205,256 |
|
| Adjusted effective tax rate |
x |
|
16 |
% |
|
x |
|
17 |
% |
|
x |
|
11 |
% |
| Tax impact |
|
|
40,640 |
|
|
|
|
39,542 |
|
|
|
|
22,578 |
|
| Adjusted operating income (tax-effected) |
|
$ |
213,360 |
|
|
|
$ |
193,060 |
|
|
|
$ |
182,678 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Average invested capital |
÷ |
$ |
1,431,266 |
|
|
÷ |
$ |
1,401,134 |
|
|
÷ |
$ |
1,298,575 |
|
| ROIC |
|
|
14.9 |
% |
|
|
|
13.8 |
% |
|
|
|
14.1 |
% |
| Weighted average cost of capital |
- |
|
9.0 |
% |
|
- |
|
9.0 |
% |
|
- |
|
8.9 |
% |
| Economic return |
|
|
5.9 |
% |
|
|
|
4.8 |
% |
|
|
|
5.2 |
% |
| Average Invested
Capital Calculations |
Jul 4,
|
|
Apr 4,
|
|
Jan 3,
|
|
Sep 27,
|
| |
2026 |
|
2026 |
|
2026 |
|
2025 |
| Equity |
$ |
1,528,752 |
|
|
$ |
1,489,800 |
|
|
$ |
1,481,063 |
|
|
$ |
1,454,588 |
|
| Plus: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt and finance lease obligations - current |
|
183,814 |
|
|
|
143,112 |
|
|
|
66,837 |
|
|
|
45,793 |
|
|
Operating lease obligations - current (2) |
|
7,616 |
|
|
|
7,758 |
|
|
|
7,943 |
|
|
|
8,253 |
|
|
Debt and finance lease obligations - long-term |
|
91,644 |
|
|
|
91,034 |
|
|
|
91,139 |
|
|
|
91,987 |
|
|
Operating lease obligations - long-term |
|
23,888 |
|
|
|
25,769 |
|
|
|
27,327 |
|
|
|
29,422 |
|
|
Less: Cash and cash equivalents |
|
(314,053 |
) |
|
|
(303,133 |
) |
|
|
(248,825 |
) |
|
|
(306,464 |
) |
| |
$ |
1,521,661 |
|
|
$ |
1,454,340 |
|
|
$ |
1,425,484 |
|
|
$ |
1,323,579 |
|
| |
|
|
|
|
|
|
|
| Average Invested Capital Calculations |
Jun 28, |
|
Mar 29, |
|
Dec 28, |
|
Sep 28, |
| |
2025 |
|
2025 |
|
2024 |
|
2024 |
| Equity |
$ |
1,419,085 |
|
|
$ |
1,351,675 |
|
|
$ |
1,319,069 |
|
|
$ |
1,324,825 |
|
| Plus: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt and finance lease obligations - current |
|
50,678 |
|
|
|
121,014 |
|
|
|
121,977 |
|
|
|
157,325 |
|
|
Operating lease obligations - current (2) |
|
8,470 |
|
|
|
9,968 |
|
|
|
14,875 |
|
|
|
14,697 |
|
|
Debt and finance lease obligations - long-term |
|
92,215 |
|
|
|
88,761 |
|
|
|
88,728 |
|
|
|
89,993 |
|
|
Operating lease obligations - long-term |
|
31,192 |
|
|
|
32,720 |
|
|
|
35,124 |
|
|
|
32,275 |
|
|
Less: Cash and cash equivalents |
|
(237,567 |
) |
|
|
(310,531 |
) |
|
|
(317,161 |
) |
|
|
(345,109 |
) |
| |
$ |
1,364,073 |
|
|
$ |
1,293,607 |
|
|
$ |
1,262,612 |
|
|
$ |
1,274,006 |
|
|
(1) |
During the three and nine months ended July 4, 2026, $12.9 million of accelerated stock-based
compensation expense was recorded in selling and administrative expenses in the accompanying
Condensed Consolidated Statements of Operations as a result of previously announced executive
retirement agreements. |
| (2) |
Included in other
accrued liabilities on the Condensed Consolidated Balance Sheets. |
| |
|

Source: Plexus